BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Tamoxifen: Interaction with CYP2D6 inhibitors

Active substance: tamoxifen

Concomitant administration of tamoxifen and strong inhibitors of the cytochrome P450 2D6 enzyme (CYP2D6) should be avoided, as a resulting reduced efficacy of tamoxifen cannot be excluded.

risk information - full text (available in German only)